Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies. The firm specializes in investing in early-stage healthcare and biotech startups, providing them with the capital, expertise, and resources necessary to develop innovative treatments and technologies.

Our firm brings Silicon Valley access and experience to Los Angeles, an emerging biotech community that is fresh, unorthodox and exciting. 

We are playing our part catalyzing the biopharma industry not just in the LA region but beyond. Technology can come from anywhere and we match our company building skills with interested entrepreneurs or academic centers.

Tmunity Therapeutics

Westlake Village BioPartners®

Congratulations to Westlake-backed 3T Biosciences on inking its second partnership with Boehringer Ingelheim focused on discovering and developing next-generation #cancer #immunotherapies.

Congratulations to Westlake-backed Kyverna Therapeutics for achieving this important milestone that offers hope to patients suffering from #multiplesclerosis!

Welcome to Patricia Turney, who has joined Westlake-backed ACELYRIN, INC. as the company’s Chief Technical Operations Officer. 

Patricia is an accomplished supply chain, manufacturing, and QC leader who will support the advancement of ACELYRIN’s robust portfolio of programs through late-stage clinical trials.

Congratulations to Westlake Village BioPartners®-backed Kyverna Therapeutics for receiving FDA Clearance of their IND for KYV-101, a novel fully human CD19 CAR T-cell therapy for the treatment of scleroderma!

Congratulations to Capsida Biotherapeutics and Kate Therapeutics, both Westlake-backed companies, on their strategic partnership to leverage Capsida's expertise and #AAV manufacturing capabilities to enable KateTx's initial internal portfolio of muscle and heart disease programs.

https://lnkd.in/gggP6FTR

Congratulations to Shephard Mpofu on joining Westlake Village BioPartners®-backed ACELYRIN, INC.. Welcome to the team!

Congratulations to Westlake-backed Kyverna on the close of their oversubscribed Series B financing round!

Exciting news for Westlake-backed ACELYRIN, and a warm welcome to Ken Lock, the company’s new Chief Commercial Officer.

https://lnkd.in/gVqcau-G

Congratulations to the next generation of leaders at Westlake Village Biopartners - Mira Chaurushiya, Ph.D., and David Allison, Ph.D.

These experienced leaders, alongside Beth Seidenberg, M.D., will manage our third fund of $450 million to incubate and grow early stage next-generation #biotechnology companies in the #LosAngeles region and beyond.

Read more: https://bit.ly/3XVyd6s

#venturecapital #biotechinvesting

COM:WESTLAKEBIO

Westlake Village BioPartners

Analysis Not Available